Healthcare -
Medical - Instruments & Supplies - NYSE - US
$ 69.65
0.259 %
$ 3.5 B
Market Cap
28.9
P/E
Price Target
Average
55.42%
Revenue Forecast
Estimate
11.48%
EBIT
Estimate
7.56%
Net Income
Estimate
48.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Haemonetics Corporation
Wall Street analysts predict an average 1-year price target for HAE of $108 , with forecasts ranging from
a
low of
$85 to a high of $120 .
HAE Lowest Price Target
Wall Street Target
85 USD
22.04%
HAE Average Price Target
Wall Street Target
108 USD
55.42%
HAE Highest Price Target
Wall Street Target
120 USD
72.29%
REVENUE FORECAST
Revenue Forecast Chart HAE
EBIT FORECAST
EBIT Forecast Chart HAE
NET INCOME FORECAST
Net Income Chart HAE